Home

Home

article image

Knowing the right procedure

DGCH promotes studies for evidence-based medicine (EbM) in surgery to establish guidelines.

Research from the USA and The Netherlands has shown that 30-40% of patients do not receive the scientifically proven best treatment for their condition, and about 25% of patients receive unnecessary treatment. Evidence-based medicine (EbM) serves to evaluate the use of diagnostic and therapeutic services. In an ideal case it ensures patients always receive the best possible medical treatment, the DGCH points out. ‘Researchers also identify ineffective or less effective therapies through relevant studies. All of which could save patients receiving unnecessary, ineffective or even damaging treatment and cut costs for healthcare systems.
EbM also can be used as a record of the effectiveness, or superiority, of an operative procedure.’ However, Professor Bauer, secretary general of the DGCH in Berlin, points out: ‘Essential progress in surgery has so far rarely been achieved through methods used in evidence-based medicine.’
Researchers mainly obtain scientific evidence through examinations of different, randomly distributed patient groups - so-called randomised controlled studies (RCTs). These are generally carried out ‘blind’: Neither doctors, nor patients, are aware which medication is being tested, which produces constant test conditions and forms the basis for meaningful comparisons. In 2000, a survey of clinical studies of surgery showed the percentage of RCTs to be only 2.8%. Of course, in surgery it is almost impossible to ‘blind’ patients and doctors. What can be achieved in drug trials using  placebos can hardly be replicated as ‘pretend’ surgical operations. That would be unethical.
With its study centre (SDGC) and linked network of five regional centres (CHIR-Net) the DGCH promotes large, multicentre clinical studies in surgery. ‘The necessary repeatability and comparability of procedures require a high degree of standardisation, not only for the surgical operation but also for the entire peri-operative treatment regime,’ Professor Bauer explains. The SDGC is able to meet these complex scientific, methodical and ethical requirements by carrying out national studies. In this way, the DGCH promotes patient-oriented research in Germany and contributes to the realisation of treatment procedures with proven effect and evident benefit for patients.
Source: www.dgch.de

This article was published on 05/01/2007

Search

 

Service

Company News

Technical infrastructure for EU funded R-bay project

Carestream Health is a major technical infrastructure provider to the EU-funded R-Bay validation project, which aims to address the uneven spread of radiologists across member states. CARESTREAM Radiology and Information Management Solutions are driving the initial test platform for the project by facilitating remote reporting of images from hospitals in Denmark, Finland and Czech Republic by clinical providers in Estonia, Lithuania and the Netherlands.

Accu-Chek® Combo – put effective diabetes management into action

At the annual congress of the European Association for the Study of Diabetes (EASD) this year in Rome, Roche Diabetes Care introduced Accu-Chek Combo – the insulin pump system that combines an insulin pump with an intelligent glucose monitoring system, a bolus calculator, and an integrated pump remote-control.

Meet us at MEDICA! Hall 7 Stand 15

The European Hospital team will be happy to hear about your research, products, R&D or trials and launches, hospital management issues, or any other aspects of your work, so that we can discuss your editorial ideas. We will also be pleased to help with any PR or advertising queries.